List of works - Colm Keane

A comprehensive analysis of the cellular and EBV-specific microRNAome in primary CNS PTLD identifies different patterns among EBV-associated tumors.

scientific article published on 4 August 2014

A high LDH to absolute lymphocyte count ratio in patients with DLBCL predicts for a poor intratumoral immune response and inferior survival.

scientific article published on 4 May 2018

B cell lymphoma progression promotes the accumulation of circulating Ly6Clo monocytes with immunosuppressive activity.

scientific article published on 18 December 2017

Biology and therapy of primary mediastinal B-cell lymphoma: current status and future directions

scientific article published on 10 February 2019

Catastrophic tumour lysis syndrome following single dose of imatinib.

scientific article

Circulating cell-free miR-494 and miR-21 are disease response biomarkers associated with interim-positron emission tomography response in patients with diffuse large B-cell lymphoma

scientific article published on 05 October 2018

Designing optimal prognostic models for diffuse large B-cell lymphoma

scientific article published on 16 April 2019

Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly expresses EBNA3A with conserved CD8 T-cell epitopes

scientific article published on 9 September 2011

Expression profiling of Epstein-Barr virus-encoded microRNAs from paraffin-embedded formalin-fixed primary Epstein-Barr virus-positive B-cell lymphoma samples.

scientific article published on 16 May 2012

Homozygous FCGR3A-158V alleles predispose to late onset neutropenia after CHOP-R for diffuse large B-cell lymphoma.

scientific article

Immune evasion via PD-1/PD-L1 on NK-cells and monocyte/macrophages is more prominent in Hodgkin lymphoma than DLBCL.

scientific article published on 15 February 2018

Multi-organ involvement with crystal-storing histiocytosis

scientific article published on 22 April 2008

Myeloid and lymphoid neoplasm with FGFR1 abnormality.

scientific article

Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing.

scientific article published on 17 April 2015

Outcomes of synchronous systemic and central nervous system (CNS) involvement of diffuse large B-cell lymphoma are dictated by the CNS disease: a collaborative study of the Australasian Lymphoma Alliance

scientific article published on 24 June 2019

Plasma microRNA are disease response biomarkers in classical Hodgkin lymphoma.

scientific article

Progression of Disease Within 24 Months in Follicular Lymphoma Is Associated With Reduced Intratumoral Immune Infiltration

scientific article published on 28 August 2019

Ratios of T-cell immune effectors and checkpoint molecules as prognostic biomarkers in diffuse large B-cell lymphoma: a population-based study

scientific article published on October 2015

Simple, rapid and inexpensive typing of common HLA class I alleles for immunological studies

scientific article published on 08 December 2018

Stem Cell-based Therapies for Sepsis

scientific article

The Hyper-CVAD chemotherapy regimen has an adverse long-term impact on the ability to mobilize peripheral blood stem cells, which can be readily circumvented by using the early cycles for mobilization

scientific article published on 01 September 2006

The T-cell Receptor Repertoire Influences the Tumor Microenvironment and Is Associated with Survival in Aggressive B-cell Lymphoma.

scientific article published on 20 September 2016

The impact of HLA class I and EBV latency-II antigen-specific CD8(+) T cells on the pathogenesis of EBV(+) Hodgkin lymphoma

scientific article

The tumour microenvironment is immuno-tolerogenic and a principal determinant of patient outcome in EBV-positive diffuse large B-cell lymphoma

scientific article published on 24 July 2019

Treatment of acute promyelocytic leukaemia in the Jehovah's Witness population

scientific article published on 06 July 2010

Tumor-specific but not nonspecific cell-free circulating DNA can be used to monitor disease response in lymphoma

scientific article published on 27 December 2011

Valproic acid combined with cytosine arabinoside in elderly patients with acute myeloid leukemia has in vitro but limited clinical activity

scientific article published on 11 January 2012

List of works by Colm Keane

A comprehensive analysis of the cellular and EBV-specific microRNAome in primary CNS PTLD identifies different patterns among EBV-associated tumors.

A high LDH to absolute lymphocyte count ratio in patients with DLBCL predicts for a poor intratumoral immune response and inferior survival.

B cell lymphoma progression promotes the accumulation of circulating Ly6Clo monocytes with immunosuppressive activity.

Biology and therapy of primary mediastinal B-cell lymphoma: current status and future directions

Catastrophic tumour lysis syndrome following single dose of imatinib.

Circulating cell-free miR-494 and miR-21 are disease response biomarkers associated with interim-positron emission tomography response in patients with diffuse large B-cell lymphoma

Designing optimal prognostic models for diffuse large B-cell lymphoma

Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly expresses EBNA3A with conserved CD8 T-cell epitopes

Expression profiling of Epstein-Barr virus-encoded microRNAs from paraffin-embedded formalin-fixed primary Epstein-Barr virus-positive B-cell lymphoma samples.

Homozygous FCGR3A-158V alleles predispose to late onset neutropenia after CHOP-R for diffuse large B-cell lymphoma.

Immune evasion via PD-1/PD-L1 on NK-cells and monocyte/macrophages is more prominent in Hodgkin lymphoma than DLBCL.

Multi-organ involvement with crystal-storing histiocytosis

Myeloid and lymphoid neoplasm with FGFR1 abnormality.

Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing.

Outcomes of synchronous systemic and central nervous system (CNS) involvement of diffuse large B-cell lymphoma are dictated by the CNS disease: a collaborative study of the Australasian Lymphoma Alliance

Plasma microRNA are disease response biomarkers in classical Hodgkin lymphoma.

Progression of Disease Within 24 Months in Follicular Lymphoma Is Associated With Reduced Intratumoral Immune Infiltration

Ratios of T-cell immune effectors and checkpoint molecules as prognostic biomarkers in diffuse large B-cell lymphoma: a population-based study

Simple, rapid and inexpensive typing of common HLA class I alleles for immunological studies

Stem Cell-based Therapies for Sepsis

The Hyper-CVAD chemotherapy regimen has an adverse long-term impact on the ability to mobilize peripheral blood stem cells, which can be readily circumvented by using the early cycles for mobilization

The T-cell Receptor Repertoire Influences the Tumor Microenvironment and Is Associated with Survival in Aggressive B-cell Lymphoma.

The impact of HLA class I and EBV latency-II antigen-specific CD8(+) T cells on the pathogenesis of EBV(+) Hodgkin lymphoma

The tumour microenvironment is immuno-tolerogenic and a principal determinant of patient outcome in EBV-positive diffuse large B-cell lymphoma

Treatment of acute promyelocytic leukaemia in the Jehovah's Witness population

Tumor-specific but not nonspecific cell-free circulating DNA can be used to monitor disease response in lymphoma

Valproic acid combined with cytosine arabinoside in elderly patients with acute myeloid leukemia has in vitro but limited clinical activity